- Home
- ETJ vs QSI Comparison
ETJ vs QSI Comparison
Compare ETJ & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETJ
- QSI
- Stock Information
- Founded
- ETJ 2007
- QSI 2013
- Country
- ETJ United States
- QSI United States
- Employees
- ETJ N/A
- QSI N/A
- Industry
- ETJ Finance Companies
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- ETJ Finance
- QSI Health Care
- Exchange
- ETJ Nasdaq
- QSI Nasdaq
- Market Cap
- ETJ 623.9M
- QSI 633.2M
- IPO Year
- ETJ N/A
- QSI N/A
- Fundamental
- Price
- ETJ $9.27
- QSI $2.38
- Analyst Decision
- ETJ
- QSI Buy
- Analyst Count
- ETJ 0
- QSI 2
- Target Price
- ETJ N/A
- QSI $3.25
- AVG Volume (30 Days)
- ETJ 175.6K
- QSI 59.6M
- Earning Date
- ETJ 01-01-0001
- QSI 02-27-2025
- Dividend Yield
- ETJ 8.30%
- QSI N/A
- EPS Growth
- ETJ N/A
- QSI N/A
- EPS
- ETJ N/A
- QSI N/A
- Revenue
- ETJ N/A
- QSI $2,266,000.00
- Revenue This Year
- ETJ N/A
- QSI $193.90
- Revenue Next Year
- ETJ N/A
- QSI $173.18
- P/E Ratio
- ETJ N/A
- QSI N/A
- Revenue Growth
- ETJ N/A
- QSI 232.26
- 52 Week Low
- ETJ $7.20
- QSI $0.61
- 52 Week High
- ETJ $8.47
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- ETJ 51.68
- QSI 50.47
- Support Level
- ETJ $9.21
- QSI $2.20
- Resistance Level
- ETJ $9.24
- QSI $2.68
- Average True Range (ATR)
- ETJ 0.11
- QSI 0.71
- MACD
- ETJ 0.00
- QSI -0.13
- Stochastic Oscillator
- ETJ 53.68
- QSI 13.52
About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.